{"organizations": [], "uuid": "d6eab42644d4aaeebbb46fdb6a1717c7a1840e31", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180226.html", "section_title": "Archive News &amp; Video for Monday, 26 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/health-aegerion/georgia-doctor-to-plead-guilty-to-disclosing-patient-info-to-aegerion-idUSL2N1QH00O", "country": "US", "domain_rank": 408, "title": "Georgia doctor to plead guilty to disclosing patient info to Aegerion", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.003, "site_type": "news", "published": "2018-02-27T08:29:00.000+02:00", "replies_count": 0, "uuid": "d6eab42644d4aaeebbb46fdb6a1717c7a1840e31"}, "author": "Nate Raymond", "url": "https://www.reuters.com/article/health-aegerion/georgia-doctor-to-plead-guilty-to-disclosing-patient-info-to-aegerion-idUSL2N1QH00O", "ord_in_thread": 0, "title": "Georgia doctor to plead guilty to disclosing patient info to Aegerion", "locations": [], "entities": {"persons": [{"name": "eduardo montana", "sentiment": "none"}, {"name": "juxtapid", "sentiment": "none"}], "locations": [{"name": "georgia", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "westlaw", "sentiment": "none"}, {"name": "aegerion pharmaceuticals inc", "sentiment": "none"}, {"name": "novelion therapeutics inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "A Georgia pediatric cardiologist is expected to plead guilty to illegally disclosing information about his patientsâ€™ health to sales representatives employed by Aegerion Pharmaceuticals Inc, according to court documents filed on Monday.\nThe case against Eduardo Montana, 55, came after the Novelion Therapeutics Inc agreed in September to pay $40.1 million to resolve U.S. investigations related to its marketing of an expensive cholesterol drug, Juxtapid.\nTo read the full story on Westlaw Practitioner Insights, click here: bit.ly/2CK0ykZ\n ", "external_links": ["http://bit.ly/2CK0ykZ", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-27T08:29:00.000+02:00", "crawled": "2018-02-27T15:11:34.016+02:00", "highlightTitle": ""}